Structured review to improve COPD management
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests a structured review process to help people with COPD who have needed multiple steroid pills in the past year. It aims to improve care and prevent future harm from the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with COPD for at least 1 year
- Age 35 or older
- Had 3 or more courses of prednisolone (steroid pills) for COPD flare-ups in the past year, each course at least 14 days apart
- Able to give informed consent
- Clinically stable for at least 4 weeks after the last flare-up or other serious illness
- Not currently taking daily steroid pills (maintenance oral steroids) or in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study tests a new system called EAPOC-COPD that helps pharmacists support people with COPD. It aims to see if the system is useful and easy to use during regular pharmacy visits.
This trial looks at whether using one or more inhalers, together with a smartphone app, can help people manage chronic obstructive pulmonary disease (COPD) better. You may be eligible if you have COPD, need “triple therapy” (three medicine types), and can use the app and surveys.
This study tests a home-based program that provides education and activity guidance for people with COPD who have been hospitalized in the past year. It aims to help you understand your condition better and stay active safely.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.